Crossmark

131I-MIBG negative progressive symptomatic metastatic paraganglioma: response and outcome with 177Lu-DOTATATE peptide receptor radionuclide therapy

Published Online: 2020-11-01

Published Print: 2021-01

Authors

Parghane, Rahul V.

Talole, Sanjay

Basu, Sandip https://orcid.org/0000-0001-6607-2558
License Information

Text and Data Mining valid from 2020-11-01

Version of Record valid from 2020-11-01
More Information

Article History

Received: 27 July 2020

Accepted: 11 October 2020

First Online: 1 November 2020

Compliance with ethical standards

:

: No Conflict-of-interest exists.

Document is current